Burford Capital Ltd
BUR NYSE Finance Services Financials FY2022βFY2025
Last close Β· Oct 23, 2026
$3.36
0.3%What Burford Capital Ltd does
No business description yet.
- Legal name
- Burford Capital Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001714174-26-000007
0001714174
Revenue and margins
Burford Capital Ltd had $413M of revenue in fiscal 2025, down 24.3% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew 26.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$29.3M in fiscal 2025, β7.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Burford Capital Ltd returned $15.3M to shareholders in fiscal 2025. The diluted share count rose 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Burford Capital Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $108M | $234M | $790M | $944M |
| Debt incl. finance leases | β | $1.5B | $1.8B | $2.1B |
| Debt / equity | β | 0.7x | 0.7x | 0.9x |
| Interest coverage | 2.5x | 8.2x | 2.9x | 1.5x |
| Total assets | β | $5.8B | $6.2B | $6.6B |
| Total liabilities | β | $2.6B | $2.9B | $3.5B |
| Shareholders' equity | $2.4B | $2.3B | $2.4B | $2.4B |
| Net debt (β = net cash) | β | $1.3B | $974M | $1.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 4 | 3 / 7 | 1 / 7 |
| Accruals ratio | β | 15.2% | β1.2% | 1.4% |
| Altman Z'' | β | β | β | β |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $319M | $1.1B | $546M | $413M |
| Operating income | $195M | $816M | $391M | $232M |
| Interest expense | $78.3M | $99.1M | $136M | $151M |
| Pretax income | $109M | $738M | $254M | $84.0M |
| Income tax | $11.6M | $20.1M | $24.0M | $11.8M |
| Net income | $30.5M | $611M | $146M | $62.6M |
| Diluted EPS | $0.14 | $2.74 | $0.66 | $0.28 |
| Diluted shares | 0.22B | 0.22B | 0.22B | 0.22B |
| Cash flow | ||||
| Cash from operations | β$466M | β$275M | $217M | β$29.0M |
| Capital expenditure | $0.4M | $3.2M | $0.7M | $0.3M |
| Free cash flow | β$467M | β$278M | $216M | β$29.3M |
| Stock-based compensation | $7.8M | $8.7M | $8.7M | $13.8M |
| Share buybacks | $3.7M | $3.8M | $5.1M | $15.3M |
| Dividends and buybacks | $3.7M | $3.8M | $5.1M | $15.3M |
| Balance sheet | ||||
| Cash and short-term investments | $108M | $234M | $790M | $944M |
| Total debt | β | $1.5B | $1.8B | $2.1B |
| Property and equipment, net | β | $3.6M | $3.4M | $3.0M |
| Goodwill | $134M | $134M | $134M | $134M |
| Total assets | β | $5.8B | $6.2B | $6.6B |
| Total liabilities | β | $2.6B | $2.9B | $3.5B |
| Shareholders' equity | $2.4B | $2.3B | $2.4B | $2.4B |
| Margins | ||||
| Operating margin | 61.1% | 75.0% | 71.5% | 56.2% |
| Net margin | 9.6% | 56.2% | 26.8% | 15.1% |
| FCF margin | β146.1% | β25.6% | 39.6% | β7.1% |
| Returns | ||||
| Return on capital | β | 22.1% | 10.4% | 5.5% |
| Return on equity | 1.3% | 26.1% | 6.2% | 2.6% |
| Return on assets | β | 10.5% | 2.4% | 1.0% |
| Return on tangible equity | 1.4% | 28.3% | 6.4% | 2.7% |
| Growth | ||||
| Revenue growth | β | 240.5% | β49.8% | β24.3% |
| Net income growth | β | 1,901.3% | β76.0% | β57.3% |
| EPS growth | β | 1,857.1% | β75.9% | β57.6% |
| FCF growth | β | β | β | β113.6% |
| Share count change | β | 0.5% | 0.1% | 0.6% |
| Financial health | ||||
| Debt / equity | β | 0.7x | 0.7x | 0.9x |
| Interest coverage | 2.5x | 8.2x | 2.9x | 1.5x |
| Capital allocation | ||||
| Capex / revenue | 0.1% | 0.3% | 0.1% | 0.1% |
| Stock comp / revenue | 2.4% | 0.8% | 1.6% | 3.3% |
| Payouts / FCF | β | β | 2.4% | β |
| Quality scores | ||||
| Piotroski F-score | β | β | 3.0 | 1.0 |
| Accruals ratio | β | 15.2% | β1.2% | 1.4% |
Source: SEC EDGAR XBRL filings (CIK 0001714174). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.